v3.26.1
SEGMENT INFORMATION (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Product and Service, Revenue [Table Text Block] The table below shows revenue reported by segment and the geographic location of customers:
   (in thousands) 
   Three
months
ended
June 30,
2026
($)		   Three
months
ended
June 30,
2025
($)		  

Six
months
ended

June 30,
2026
($)

  

Six
months
ended

June 30,
2025
($)

 
                 
Life Sciences segment                
Wellness and lifestyle   9    6    32    19 
White labeling services   256    322    550    639 
Total   265    328    582    658 
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue [Table Text Block] The table below shows the loss before income tax and other (expense)/income categories regularly provided to the CODM in assessing the Company’s one reportable segment, “Life Sciences,” segment performance:
   (in thousands)
Three months ended
June 30,		 
   2026($)   2025($) 
United States (U.S.)        
Revenue   265    328 
Cost of revenue   (217)   (174)
Selling, general, and administrative expenses   (695)   (895)
Research and development expenses   (761)   (383)
Common stock-based compensation and expenses, net   (727)   (224)
Operating loss   (2,135)   (1,348)
Others          
Selling, general, and administrative expenses   (255)   (200)
Research and development expenses   (374)   (128)
Common stock-based compensation and expenses, net   (20)   (229)
Operating loss   (649)   (557)
Total Operating loss   (2,784)   (1,905)

 

   (in thousands)
Six months ended
June 30,		 
   2026($)   2025($) 
United States (U.S.)        
Revenue   582    658 
Cost of revenue   (479)   (350)
Selling, general, and administrative expenses   (1,408)   (1,010)
Research and development expenses   (1,212)   (932)
Common stock-based compensation and expenses, net   (1,615)   (645)
Operating loss   (4,132)   (2,279)
Others          
Selling, general, and administrative expenses   (403)   (402)
Research and development expenses   (566)   (375)
Common stock-based compensation and expenses, net   (141)   (262)
Operating loss   (1,110)   (1,039)
Total Operating loss   (5,242)   (3,318)
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Table Text Block] The table below shows the non-current assets other than financial instruments held in the country of domicile and foreign countries.
   (in thousands) 
Nature of assets  USA
(Country
of Domicile)
($)		   Foreign
Countries
(India and
Colombia)
($)		   Total
as of
June 30,
2026
($)		 
Intangible assets, net   5,507    -    5,507 
Property, plant, and equipment, net   2,004    65    2,069 
Claims and advances   410    246    656 
Operating lease asset   -    -    - 
Total non-current assets   7,921    311    8,232 

 

    (in thousands)  
Nature of assets   USA
(Country of
Domicile)
($)		     Foreign
Countries
(India and
Colombia)
($)		     Total
as of
December 31,
2025
($)		  
Intangible assets, net     5,101       -       5,101  
Property, plant, and equipment, net     2,073       68       2,141  
Claims and advances     410       259       669  
Operating lease asset     -       11       11  
Total non-current assets     7,584       338       7,922